OTC Derivatives Trade Reporting Costs 'Will Rise'

Survey finds investment banks have already spent an average of $25 million

paul-gibson-sapient2
Paul Gibson, consultant, Sapient

The majority of market participants expect the cost of over-the-counter derivatives trade reporting to rise, a new survey has found.

Sapient Global Markets this month released the findings, gathered by canvassing some 50 delegates to the 30th annual general meeting of the International Swaps and Derivatives Association (ISDA), held in Montreal in April.

About 50% of respondents were sell-side participants and about 33% buy-side. The rest were broker-dealers.

Paul Gibson, a consultant at Sapient

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

CME: CFTC OKs clearing move to Google Cloud

The CFTC has given the Chicago-based exchange approval to run its clearing and settlement infrastructure on the Google Cloud Platform, while the exchange and vendor have extended their partnership to last until at least 2037.

Cutting through the hype surrounding the FDTA rulemaking process

A bill requiring US regulators and institutions to adopt a machine-readable data framework for reporting purposes applies to entity identifiers, but not security identifiers, in a crucial difference, writes Scott Preiss, SVP and global head of Cusip Global Services.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here